Mydecine Innovations Announces Amended Press Release Relating to the Closing of Prospectus Supplement Financing
20 sept. 2023 12h12 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering...
Mydecine Innovations Announces Closing of Prospectus Supplement Financing
19 sept. 2023 16h01 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering...
Mydecine Innovations Group Files Prospectus Supplement
15 sept. 2023 17h30 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering...
Mydecine Announces Conditional Approval of CSE Listing
30 août 2023 16h01 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO:MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), is pleased to announce that it has...
Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2023
14 août 2023 20h32 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company engineering the next wave of...
Mydecine Innovations Group Provides Corporate Update
21 juil. 2023 17h30 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, July 21, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the...
Mydecine Reports its Special Meeting Results
05 juil. 2023 16h01 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering...
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
29 mai 2023 19h42 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the...
Mydecine Reports Financial Results for the First Quarter of Fiscal Year 2023
16 mai 2023 16h01 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company engineering the...
Mydecine Reports its 2023 Annual General Shareholders' Meeting Results
10 mai 2023 16h05 HE
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the...